Affiliation:
1. Renal Research Laboratory, Kolling Institute of Medical Research, Royal North Shore Hospital, The University of Sydney, Sydney, NSW 2065, Australia
2. Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UK
3. Faculty of Biology, Medicine & Health, The University of Manchester, Manchester M1 7HR, UK
Abstract
The number of people living with chronic kidney disease (CKD) is growing as our global population continues to expand. With aging, diabetes, and cardiovascular disease being major harbingers of kidney disease, the number of people diagnosed with diabetic kidney disease (DKD) has grown concurrently. Poor clinical outcomes in DKD could be influenced by an array of factors—inadequate glycemic control, obesity, metabolic acidosis, anemia, cellular senescence, infection and inflammation, cognitive impairment, reduced physical exercise threshold, and, importantly, malnutrition contributing to protein-energy wasting, sarcopenia, and frailty. Amongst the various causes of malnutrition in DKD, the metabolic mechanisms of vitamin B (B1 (Thiamine), B2 (Riboflavin), B3 (Niacin/Nicotinamide), B5 (Pantothenic Acid), B6 (Pyridoxine), B8 (Biotin), B9 (Folate), and B12 (Cobalamin)) deficiency and its clinical impact has garnered greater scientific interest over the past decade. There remains extensive debate on the biochemical intricacies of vitamin B metabolic pathways and how their deficiencies may affect the development of CKD, diabetes, and subsequently DKD, and vice-versa. Our article provides a review of updated evidence on the biochemical and physiological properties of the vitamin B sub-forms in normal states, and how vitamin B deficiency and defects in their metabolic pathways may influence CKD/DKD pathophysiology, and in reverse how CKD/DKD progression may affect vitamin B metabolism. We hope our article increases awareness of vitamin B deficiency in DKD and the complex physiological associations that exist between vitamin B deficiency, diabetes, and CKD. Further research efforts are needed going forward to address the knowledge gaps on this topic.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference177 articles.
1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Levin;Kidney Int. Suppl.,2013
2. Trends in prevalence of chronic kidney disease in the United States;Murphy;Ann. Intern. Med.,2016
3. Obesity and chronic kidney disease in US adults with type 1 and type 2 diabetes mellitus;Wallace;J. Endocrinol. Metab.,2022
4. A study of the natural history of diabetic kidney disease (DKD);Altemtam;Nephrol. Dial. Transplant.,2012
5. Prevalence of chronic kidney disease in Asia: A systematic review and analysis;Liyanage;BMJ Glob. Health,2022